Boosting compounds called adjuvants complicate licensing of pandemic vaccines

TORONTO - As swine flu vaccine becomes available in coming months, boosting compounds known as adjuvants may stretch out limited supplies. But they also pose special challenges for vaccine regulatory agencies in places like Canada and the United States....More